Purpose
The purpose of this study was to investigate the role of biantennary branching glycans of α1-acid glycoprotein (AGP) and its genetic variants in the enantioselective binding of oxybutynin (OXY).
Method
Human native AGP was separated using imminodiacetate–copper (II) affinity chromatography into two fractions, the A variant and a mixture of the F1 and S variants (F1–S). These fractionated AGPs were further separated by concanavalin A affinity chromatography into two fractions, with and without biantenarry glycans. An on-line high-performance liquid chromatography (HPLC) system consisting of a high-performance frontal analysis column, an extraction column, and an analytical HPLC column was developed to determine the binding affinities of OXY enantiomers for respective AGP species.
Results
The total binding affinity as well as the enantiomeric selectivity of OXY in the F1–S mixed variant was significantly higher than that for the A variant, indicating that the chiral recognition ability of native AGP for the OXY enantiomers highly depends on the F1–S mixed variant. Furthermore, not only the genetic variants but also bianntenary glycans of AGP affect the binding affinity of OXY and are also responsible for the enantioselectivity.
Conclusions
Both genetic variants and glycan structures significantly contribute to the enantioselectivity and the binding affinity of OXY.
Similar content being viewed by others
References
R. H. Levy T. A. Moreland (1984) ArticleTitleRationale for monitoring free drug levels Clin. Pharmacokinet. 9 1–9 Occurrence Handle6705421 Occurrence Handle1:CAS:528:DyaL2cXpsF2qtg%3D%3D
J. D. Wright F. D. Boudinot M. R. Ujhelyi (1996) ArticleTitleMeasurement and analysis of unbound drug concentrations Clin. Pharmacokinet. 30 445–462 Occurrence Handle8792057 Occurrence Handle1:CAS:528:DyaK28Xktlahtr4%3D Occurrence Handle10.2165/00003088-199630060-00003
T. Noctor I. W. Wainer (1993) Drug Stereochemistry EditionNumber2 Dekker New York
G. T. Tucker M. S. Lennard (1990) ArticleTitleEnantiomer specific pharmacokinetics Pharmacol. Ther. 45 309–329 Occurrence Handle2405439 Occurrence Handle1:CAS:528:DyaK3cXmvFamug%3D%3D Occurrence Handle10.1016/0163-7258(90)90069-E
A. Shibukawa Y. Yoshikawa T. Kimura T. Nakagawa I. W. Wainer (2002) ArticleTitleBinding study of desethyloxybutynin using high-performance frontal analysis method J. Chromatogr. B 768 189–197 Occurrence Handle1:CAS:528:DC%2BD38XhtVKgs78%3D Occurrence Handle10.1016/S0378-4347(01)00499-6
A. Shibukawa N. Ishizawa T. Kimura T. Nakagawa I. W. Wainer (2002) ArticleTitlePlasma protein binding study of oxybutynin by high-performance frontal analysis J. Chromatogr. B. 768 177–188 Occurrence Handle1:CAS:528:DC%2BD38XhtVKgsrY%3D Occurrence Handle10.1016/S0378-4347(01)00497-2
A. Shibukawa T. Nakagawa N. Nishimura M. Miyake H. Tanaka (1989) ArticleTitleDetermination of free drug in protein binding equilibrium by high-performance frontal analysis using internal-surface reversed-phase silica support Chem. Pharm. Bull. 37 707–711 Occurrence Handle2752482
A. Shibukawa N. Nishimura K. Nomura Y. Kuroda T. Nakagawa (1990) ArticleTitleSimultaneous determination of the free and total carbamazepine concentrations in human plasma by high–performance frontal analysis using an internal–surface reversed-phase silica support Chem. Pharm. Bull. 38 443–447 Occurrence Handle2159856 Occurrence Handle1:CAS:528:DyaK3cXhvFWhurw%3D
A. Shibukawa M. Nagao Y. Kuroda T. Nakagawa (1990) ArticleTitleStereoselective determination of free warfarin concentration in protein binding equilibrium using direct sample injection and an on-line liquid chromatographic system Anal. Chem. 62 712–716 Occurrence Handle2327588 Occurrence Handle1:CAS:528:DyaK3cXhtlWktLw%3D Occurrence Handle10.1021/ac00206a013
A. Shibukawa A. Terakita J. He T. Nakagawa (1992) ArticleTitleHigh-performance frontal analysis–high-performance liquid chromatographic system for stereoselective determination of unbound ketoprofen enantiomers in plasma after direct sample injection J. Pharm. Sci. 81 710–715 Occurrence Handle1403710 Occurrence Handle1:CAS:528:DyaK3sXnt12qsQ%3D%3D
T. Kimura K. Nakanishi T. Nakagawa A. Shibukawa K. Matsuzaki (2005) ArticleTitleHigh-performance frontal analysis of the binding of thyroxine enantiomers to human serum albumin Pharm. Res. 22 667–675 Occurrence Handle15846475 Occurrence Handle1:CAS:528:DC%2BD2MXjsFags7Y%3D Occurrence Handle10.1007/s11095-005-2485-y
T. Kimura K. Nakanishi T. Nakagawa A. Shibukawa K. Matsuzaki (2005) ArticleTitleSimultaneous determination of unbound thyroid hormones in human plasma using high performance frontal analysis with electrochemical detection J. Pharm. Biomed. Anal. 15 204–209 Occurrence Handle10.1016/j.jpba.2004.12.018 Occurrence Handle1:CAS:528:DC%2BD2MXltVegsrc%3D
A. Shibukawa Y. Kuroda T. Nakagawa (1999) ArticleTitleHigh-performance frontal analysis for drug–protein binding study J. Pharm. Biomed. Anal. 18 1047–1055 Occurrence Handle9925341 Occurrence Handle1:CAS:528:DyaK1MXotVShuw%3D%3D Occurrence Handle10.1016/S0731-7085(98)00201-5
G. A. Turner (1992) ArticleTitleN-Glycosylation of serum proteins in disease and its investigation using lectins Clin. Chim. Acta 208 149–171 Occurrence Handle1499135 Occurrence Handle1:CAS:528:DyaK38Xlt12jsr4%3D Occurrence Handle10.1016/0009-8981(92)90073-Y
J. M. H. Kremer (1988) ArticleTitleDrug binding to human alpha-1-acid glycoprotein in health and disease Pharmacol. Rev. 40 1–47 Occurrence Handle3064105 Occurrence Handle1:CAS:528:DyaL1cXlsVWqs74%3D Occurrence Handle10.1159/000199636
W. Dijk (1995) ArticleTitleAlpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function Glycoconjugate J. 12 227–233 Occurrence Handle10.1007/BF00731324
L. Dente A. Metspalu (1987) ArticleTitleStructure and expression of the genes coding for human alpha 1-acid glycoprotein EMBO J. 6 2289–2296 Occurrence Handle2822385 Occurrence Handle1:CAS:528:DyaL1cXhvF2iur4%3D
I. Yuasa K. Suenaga K. Umetsu K. Ito M. Robinet-Levy (1987) ArticleTitleOrosomucoid (ORM) typing by isoelectric focusing: evidence for gene duplication of ORM1 and genetic polymorphism of ORM2 Hum. Genet. 77 255–258 Occurrence Handle3679210 Occurrence Handle1:CAS:528:DyaL1cXht12itbc%3D Occurrence Handle10.1007/BF00284480
C. B. Eap P. Baumann (1988) ArticleTitleIsoelectric focusing of alpha-1 acid glycoprotein (orosomucoid) in immobilized pH-gradients with 8M urea: detection of its desialylated variants using an alkaline phosphatase-linked secondary antibody system Electrophoresis 9 650–654 Occurrence Handle3243228 Occurrence Handle1:CAS:528:DyaL1MXjs1Chtw%3D%3D Occurrence Handle10.1002/elps.1150091005
L. Tomei C. B. Eap P. Baumann L. Dente (1989) ArticleTitleUse of transgenic mice for the characterization of human alpha 1-acid glycoprotein (orosomucoid) variants Hum. Genet. 84 89–91 Occurrence Handle2606483 Occurrence Handle1:CAS:528:DyaK3cXhsFKjtbo%3D Occurrence Handle10.1007/BF00210681
F. Herve E. Gomas J. P. Tillement (1996) ArticleTitleBinding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycoprotein Pharmacogenetics 6 403–415 Occurrence Handle8946472 Occurrence Handle1:CAS:528:DyaK2sXjs1CktQ%3D%3D
T. Nakagawa S. Kishino S. Itoh M. Sugawara K. Miyazaki (2003) ArticleTitleDifferential binding of disopyramid and warfarin enantiomers to human α1-acid glycoprotein variants Br. J. Clin. Pharmacol. 56 664–669 Occurrence Handle14616427 Occurrence Handle1:CAS:528:DC%2BD2cXivFSmsQ%3D%3D Occurrence Handle10.1046/j.1365-2125.2003.01909.x
H. Shiono A. Shibukawa T. Nakagawa (1997) ArticleTitleEffect of sialic acid residues of human alpha 1-acid glycoprotein on stereoselectivity in basic drug–protein binding Chirality 9 291–296 Occurrence Handle9176995 Occurrence Handle1:CAS:528:DyaK2sXjsF2ntLw%3D Occurrence Handle10.1002/(SICI)1520-636X(1997)9:3<291::AID-CHIR15>3.0.CO;2-I
N. F. Fraeyman C. D. Dello F. M. Belpaire (1988) ArticleTitleAlpha 1-acid glycoprotein concentration and molecular heterogeneity: relationship to oxprenolol binding in serum from healthy volunteers and patients with lung carcinoma or cirrhosis Br. J. Clin. Pharmacol. 25 733–740 Occurrence Handle3203044 Occurrence Handle1:CAS:528:DyaL1cXks1Kgsrg%3D
F. Herve J. C. Duche J. P. Tillement (1993) ArticleTitleFractionation of the genetic variants of human α1-acid glycoprotein in the native form by chromatography on an immobilized copper (II) affinity adsorbent: heterogeneity of the separate variants by isoelectrofocusing and by concanavalin A affinity chromatography J. Chromatogr. B. 615 47–57 Occurrence Handle1:CAS:528:DyaK3sXks1Kqsrw%3D
F. Hervé D. Tremblay J. Tillement J. Barré (2003) ArticleTitleGlycosylation study of the major genetic variants of human α1-acid glycoprotein and of their pharmacokinetics in the rat J. Chromatogr. B. 798 283–294 Occurrence Handle10.1016/j.jchromb.2003.09.057 Occurrence Handle1:CAS:528:DC%2BD3sXpt1Srurw%3D
F. Herve J. P. Tillement (1996) ArticleTitleTwo-step chromatographic purification of human plasma α1-acid glycoprotein Its application to the purification of rare phenotype samples of the protein and their study by chromatography on immobilized metal chelate affinity adsorbent J. Chromatogr. B. 678 1–14 Occurrence Handle1:CAS:528:DyaK28XisFaiurk%3D
M. F. Bierhuizen W. V. Dijk (1988) ArticleTitleGlycosylation of three molecular forms of human alpha 1-acid glycoprotein having different interactions with concanavalin A. Variations in the occurrence of di-, tri-, and tetraantennary glycans and the degree of sialylation Eur. J. Biochem. 175 387–394 Occurrence Handle3402460 Occurrence Handle1:CAS:528:DyaL1cXltVKktbY%3D Occurrence Handle10.1111/j.1432-1033.1988.tb14208.x
I. Nicollet J. P. Lebreton M. Hiron (1981) ArticleTitleEvidence for alpha-1-acid glycoprotein populations of different pI values after concanavalin A affinity chromatography. Study of their evolution during inflammation in man Biochem. Biophys. Acta 668 235–245 Occurrence Handle7225409 Occurrence Handle1:CAS:528:DyaL3MXhvFSitr8%3D
E. R. Smith S. E. Wright G. Aberg Y. Fang J. R. McCullough (1998) ArticleTitleComparison of the antimuscarinic and antispasmodic actions of racemic oxybutynin and desethyloxybutynin and their enantiomers with those of racemic terodiline Arzneim.-Forsch. 48 1012–1018 Occurrence Handle1:CAS:528:DyaK1cXntV2nsb8%3D
D. R. P. Gray (2003) ArticleTitleClinical pharmacokinetics of drugs used to treat urge incontinence Clin. Pharmacokinet. 42 1243–1285 Occurrence Handle10.2165/00003088-200342140-00004
N. A. L. Mohamed Y. Kuroda A. Shibukawa T. Nakagawa S. E. Samia E. Gizawy F. A. Hassan M. E. E. Kommos (2000) ArticleTitleEnantioselective binding analysis of verapamil to plasma lipoproteins by capillary electrophoresis–frontal analysis J. Chromatogr. A. 875 447–453 Occurrence Handle10839164 Occurrence Handle1:CAS:528:DC%2BD3cXisFGgt7Y%3D Occurrence Handle10.1016/S0021-9673(99)01288-1
F. Herve M. C. Millot (1992) ArticleTitlepH titration curves of the desialylated human alpha 1-acid glycoprotein variants by combined isoelectrofocusing–electrophoresis: utilization in the development of a fractionation method for the protein variants by chromatography on immobilized metal affinity adsorbent J. Chromatogr. 577 43–59 Occurrence Handle1400745 Occurrence Handle1:CAS:528:DyaK38Xkt1altrw%3D
F. Herve J. C. Duche M. C. Jaurand (1998) ArticleTitleChanges in expression and microheterogeneity of the genetic variants of human α1-acid glycoprotein in malignant mesothelioma J. Chromatogr. B. 715 111–123 Occurrence Handle1:CAS:528:DyaK1cXlvFeksbc%3D
W. V. Dijk O. Pos L. Dente P. Baumann C. B. Eap (1991) ArticleTitleInflammation-induced changes in expression and glycosylation of genetic variants of alpha 1-acid glycoprotein. Studies with human sera, primary cultures of human hepatocytes and transgenic mice Biochem. J. 276 343–347 Occurrence Handle1646598
A. Mackiewicz K. Mackiewicz (1995) ArticleTitleGlycoforms of serum alpha 1-acid glycoprotein as markers of inflammation and cancer Glycoconjugate J. 12 241–247 Occurrence Handle1:CAS:528:DyaK2MXntFGktLY%3D Occurrence Handle10.1007/BF00731326
I. Nicollet J.-P. Lebreton M. Fontaine M. Hiron (1981) ArticleTitleEvidence for alpha-1-acid glycoprotein populations of different pI values after concanavalin A affinity chromatography. Study of their evolution during inflammation in man Biochim. Biophys. Acta 668 235–245 Occurrence Handle7225409 Occurrence Handle1:CAS:528:DyaL3MXhvFSitr8%3D
F. Herve (1993) ArticleTitleEvidence for differences in the binding of drugs to the two main genetic variants of human alpha 1-acid glycoprotein Br. J. Clin. Pharmacol. 36 241–249 Occurrence Handle9114911 Occurrence Handle1:CAS:528:DyaK3sXmsVSru7Y%3D
O. Pos W. Dijk (1990) ArticleTitleCon A–nonreactive human alpha 1-acid glycoprotein (AGP) is more effective in modulation of lymphocyte proliferation than Con A-reactive AGP serum variants Inflammation 14 133–141 Occurrence Handle2323809 Occurrence Handle1:CAS:528:DyaK3cXitleqsrg%3D Occurrence Handle10.1007/BF00917452
Acknowledgments
The authors wish to acknowledge the advice provided by Professor Terumichi Nakagawa (Setsunan University, Japan). The authors also thank Professor Irving W. Wainer (National Insitute on Aging, U.S.A.) for providing samples. This research was supported by the 21st Century Center of Excellence Program “Knowledge Information Infrastructure for Genome Science” from the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kimura, T., Shibukawa, A. & Matsuzaki, K. Biantennary Glycans as Well as Genetic Variants of α1-Acid Glycoprotein Control the Enantioselectivity and Binding Affinity of Oxybutynin. Pharm Res 23, 1038–1042 (2006). https://doi.org/10.1007/s11095-006-9777-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-9777-8